News BeyondSpring looks to tap China for lung cancer drug develop... Company's alliance in huge lung cancer market could pay off
News Scotland's Opdivo decision sparks funding row Patients in Scotland will receive lung cancer drug, those in England will not.
News Potential lung cancer use for Novartis' melanoma combo New trial suggests use in lung cancer with same mutation.
News Data builds on Roche's dominance in primary progressive MS Roche looks on track to add oral BTK inhibitor fenebrutinib to treatment options for primary progressive multiple sclerosis.
Sales & Marketing Sponsored How to meet your physicians where they are online A pharma company’s core mission is to improve patient outcomes. This hinges on effectively influencing HCP clinical behaviour and driving disease education.
